rs386833813
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_003982.4(SLC7A7):c.254_255del(p.Phe85TrpfsTer13) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 31)
Consequence
SLC7A7
NM_003982.4 frameshift
NM_003982.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.51
Genes affected
SLC7A7 (HGNC:11065): (solute carrier family 7 member 7) The protein encoded by this gene is the light subunit of a cationic amino acid transporter. This sodium-independent transporter is formed when the light subunit encoded by this gene dimerizes with the heavy subunit transporter protein SLC3A2. This transporter is found in epithelial cell membranes where it transfers cationic and large neutral amino acids from the cell to the extracellular space. Defects in this gene are a cause of lysinuric protein intolerance (LPI). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 14-22813143-CAA-C is Pathogenic according to our data. Variant chr14-22813143-CAA-C is described in ClinVar as [Pathogenic]. Clinvar id is 56365.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr14-22813143-CAA-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC7A7 | NM_003982.4 | c.254_255del | p.Phe85TrpfsTer13 | frameshift_variant | 2/10 | ENST00000674313.1 | NP_003973.3 | |
SLC7A7 | NM_001126105.3 | c.254_255del | p.Phe85TrpfsTer13 | frameshift_variant | 3/11 | NP_001119577.1 | ||
SLC7A7 | NM_001126106.4 | c.254_255del | p.Phe85TrpfsTer13 | frameshift_variant | 3/11 | NP_001119578.1 | ||
SLC7A7 | XM_011537299.2 | c.254_255del | p.Phe85TrpfsTer13 | frameshift_variant | 2/10 | XP_011535601.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC7A7 | ENST00000674313.1 | c.254_255del | p.Phe85TrpfsTer13 | frameshift_variant | 2/10 | NM_003982.4 | ENSP00000501493 | P1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Lysinuric protein intolerance Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Nov 06, 2023 | Criteria applied: PVS1,PM3,PM2_SUP - |
Likely pathogenic, no assertion criteria provided | literature only | Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM) | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at